Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors

Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors

In recent years, Peroxisome Proliferator-Activated Receptors (PPARs) have been connected to the endocannabinoid system. These nuclear receptors indeed mediate the effects of anandamide and similar substances such as oleoyl-ethanolamide and palmitoyl-ethanolamide. An increasing body of literature des...

Full description

Bibliographic Details
Main Authors:	Leonardo Brunetti, Antonio Carrieri, Luca Piemontese, Paolo Tortorella, Fulvio Loiodice, Antonio Laghezza
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	International Journal of Molecular Sciences
Subjects:	multitarget anandamide FAAH PPARs Alzheimer’s disease endocannabinoids
Online Access:	https://www.mdpi.com/1422-0067/21/19/7026

Similar Items

The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation
by: Ahmet Ulugöl
Published: (2014-06-01)

Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM‐833 [(R)‐N‐(pyridazin‐3‐yl)‐4‐(7‐(trifluoromethyl)chroman‐4‐yl)piperazine‐1‐carboxamide] in rats: Potential for the treatment of inflammatory pain
by: Toshiya Endo, et al.
Published: (2020-04-01)

Evaluating Fatty Acid Amide Hydrolase as a Suitable Target for Sleep Promotion in a Transgenic TauP301S Mouse Model of Neurodegeneration
by: Shenée C. Martin, et al.
Published: (2024-02-01)

Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls
by: Jennifer Spohrs, et al.
Published: (2023-12-01)

A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE)
by: Rosalba Leuci, et al.
Published: (2022-01-01)

A genetic variant of fatty acid amide hydrolase (FAAH) exacerbates hormone-mediated orexigenic feeding in mice
by: Georgia Balsevich, et al.
Published: (2023-04-01)

Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice
by: E.L. von Rüden, et al.
Published: (2015-05-01)

A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
by: Dale Deutsch
Published: (2016-10-01)

Endocannabinoid Systetm: Neuropharmacological Implications
by: Vivek Kumar Sharma, et al.
Published: (2016-06-01)

Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
by: Justin Matheson, et al.
Published: (2021-12-01)

Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes
by: Natalia Battista, et al.
Published: (2007-07-01)

Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System
by: Ana Lago-Fernandez, et al.
Published: (2021-01-01)

Effects of endocannabinoids in pentylenetetrazole induced seizures in mice
by: Engin Yücel, et al.
Published: (2020-10-01)

Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain
by: Adriana Della Pietra, et al.
Published: (2022-04-01)

Endocannabinoid System and Migraine Pain: An Update
by: Rosaria Greco, et al.
Published: (2018-03-01)

An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers
by: Nicole L. Stone, et al.
Published: (2018-11-01)

The endocannabinoid system: an overview
by: Natalia eBattista, et al.
Published: (2012-03-01)

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
by: Leonardo Brunetti, et al.
Published: (2020-01-01)

From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia
by: Kurt Leroy Hoffman
Published: (2021-07-01)

Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation
by: Marta Lombardi, et al.
Published: (2024-02-01)

Endocannabinoids, Related Compounds and Their Metabolic Routes
by: Filomena Fezza, et al.
Published: (2014-10-01)

Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis
by: Marek Toczek, et al.
Published: (2023-06-01)

A Guide to Targeting the Endocannabinoid System in Drug Design
by: Adam Stasiulewicz, et al.
Published: (2020-04-01)

The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
by: Robert Ramer, et al.
Published: (2021-11-01)

Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case–control study
by: Hadi Bazyar, et al.
Published: (2022-11-01)

Endocannabinoid System in Pregnancy Maintenance and Labor: A Mini-Review
by: Melissa L. Kozakiewicz, et al.
Published: (2021-06-01)

Human Milk Endocannabinoid Levels as a Function of Obesity and Diurnal Rhythm
by: Palika Datta, et al.
Published: (2021-07-01)

Presence of the Endocannabinoid System in the Inferior Pulvinar of the Vervet Monkey
by: Catarina Micaelo-Fernandes, et al.
Published: (2021-06-01)

Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
by: Irene Santos-García, et al.
Published: (2023-05-01)

Crosstalk Between Nitric Oxide and Endocannabinoid Signaling Pathways in Normal and Pathological Placentation
by: Cyntia E. Abán, et al.
Published: (2018-12-01)

Intrathecal morphine administration reduces postoperative pain and peripheral endocannabinoid levels in total knee arthroplasty patients: a randomized clinical trial
by: Martin Kaczocha, et al.
Published: (2018-02-01)

Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
by: Kazuhito Tsuboi, et al.
Published: (2018-10-01)

Effect of MCH1, a fatty-acid amide hydrolase inhibitor, on the depressive-like behavior and gene expression of endocannabinoid and dopaminergic-signaling system in the mouse nucleus accumbens
by: C. Medina-Saldivar, et al.
Published: (2024-02-01)

The interplay between kisspeptin and endocannabinoid systems modulates male hypothalamic and gonadic control of reproduction in vivo
by: Marianna Marino, et al.
Published: (2023-10-01)

Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy
by: S. Alisha Epps
Published: (2022-10-01)

Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice
by: Aguirre Carolina A, et al.
Published: (2012-07-01)

Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats
by: Aidan Levine, et al.
Published: (2021-11-01)

Investigating the Synergistic Effect of Palmitoylethanolamide and Ganaxolone in PTZ-induced Tonic-clonic Seizures
by: Hesamodin Bagheripoor, et al.
Published: (2023-03-01)

Inactivation of Anandamide Signaling: A Continuing Debate
by: Wael E. Houssen, et al.
Published: (2010-10-01)

Misidentification of prostamides as prostaglandins
by: Michelle Glass, et al.
Published: (2005-07-01)